from Reuters: Health News https://ift.tt/2nP9nIE
Monday, 30 September 2019
GlaxoSmithKline's cancer therapy cuts risk of disease progression or death by 38%
GlaxoSmithKline plc said on Monday its maintenance therapy for a form of ovarian cancer reduced the risk of disease progression or death by 38% in a late-stage study in cancer patients.
from Reuters: Health News https://ift.tt/2nP9nIE
from Reuters: Health News https://ift.tt/2nP9nIE
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment